Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 86

    1.

    Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.

    Fournier A, Oprisiu-Fournier R, Serot JM, Godefroy O, Achard JM, Faure S, Mazouz H, Temmar M, Albu A, Bordet R, Hanon O, Gueyffier F, Wang J, Black S, Sato N.

    Expert Rev Neurother. 2009 Sep;9(9):1413-31.PMID: 19769454 [PubMed - in process]Related articles

    2.

    Cognitive therapy versus Rogerian supportive therapy in borderline personality disorder. Two-year follow-up of a controlled pilot study.

    Cottraux J, Note ID, Boutitie F, Milliery M, Genouihlac V, Yao SN, Note B, Mollard E, Bonasse F, Gaillard S, Djamoussian D, Guillard Cde M, Culem A, Gueyffier F.

    Psychother Psychosom. 2009;78(5):307-16. Epub 2009 Jul 24.PMID: 19628959 [PubMed - in process]Related articles

    3.

    [Principles of evaluation of diagnostic tests]

    Kassai B, Gueyffier F, Rabilloud M.

    Rev Prat. 2009 Mar 20;59(3):375-9. French. No abstract available. PMID: 19408883 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Application of clinical trial results]

    Gueyffier F, Delahaye F.

    Rev Prat. 2009 Feb 20;59(2):241-4. French. No abstract available. PMID: 19317144 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Foundations of randomized clinical trials]

    Gueyffier F, Delahaye F.

    Rev Prat. 2009 Jan 20;59(1):95-7. French. No abstract available. PMID: 19253892 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Critical reading of articles: an essential aspect of modern medical training]

    Gueyffier F.

    Rev Prat. 2009 Jan 20;59(1):20-4. Review. French. PMID: 19253875 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Active drug monitoring of adverse drug reactions in pediatric emergency department]

    Planchamp F, Nguyen KA, Vial T, Nasri S, Javouhey E, Gillet Y, Ranchin B, Villard F, Floret D, Cochat P, Gueyffier F, Kassaï B; Groupe de travail pharmacovigilance en pédiatrie.

    Arch Pediatr. 2009 Feb;16(2):106-11. Epub 2008 Dec 30. French. PMID: 19117738 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Some reflexions about double blind]

    Boussageon R, Gueyffier F, Moreau A, Gansel Y, Boussageon V.

    Encephale. 2008 Sep;34(4):347-51. Epub 2008 Jan 11. Review. French. PMID: 18922236 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Critical of the additive model of the randomized controlled trial]

    Boussageon R, Gueyffier F, Bejan-Angoulvant T, Felden-Dominiak G.

    Therapie. 2008 Jan-Feb;63(1):29-35. Epub 2008 Apr 4. Review. French. PMID: 18387273 [PubMed - indexed for MEDLINE]Related articles

    10.

    New insights on the relation between untreated and treated outcomes for a given therapy effect model is not necessarily linear.

    Boissel JP, Cucherat M, Nony P, Chabaud S, Gueyffier F, Wright JM, Lièvre M, Leizorovicz A.

    J Clin Epidemiol. 2008 Mar;61(3):301-7. Epub 2007 Nov 28.PMID: 18226755 [PubMed - indexed for MEDLINE]Related articles

    11.

    Meta-analysis of continuous outcomes combining individual patient data and aggregate data.

    Riley RD, Lambert PC, Staessen JA, Wang J, Gueyffier F, Thijs L, Boutitie F.

    Stat Med. 2008 May 20;27(11):1870-93.PMID: 18069721 [PubMed - indexed for MEDLINE]Related articles

    12.

    The JIKEI trial.

    Boutitie F, Gueyffier F, Achard JM, Temmar M, Fournier A.

    Lancet. 2007 Dec 1;370(9602):1825-6. No abstract available. PMID: 18061051 [PubMed - indexed for MEDLINE]Related articles

    13.

    Severe myoclonic epilepsy in infancy: a systematic review and a meta-analysis of individual patient data.

    Kassaï B, Chiron C, Augier S, Cucherat M, Rey E, Gueyffier F, Guerrini R, Vincent J, Dulac O, Pons G.

    Epilepsia. 2008 Feb;49(2):343-8. Epub 2007 Nov 19. Review.PMID: 18028411 [PubMed - indexed for MEDLINE]Related articles

    14.

    Do we need to assess the effect of treatment withdrawal? The paradigm of life-long prevention.

    Gueyffier F, Bejan-Angoulvant T.

    Stroke. 2007 Oct;38(10):2629-30. Epub 2007 Aug 30. No abstract available. PMID: 17761906 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Does a change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke? A meta-analysis of trials according to treatment with potentially different effects on angiotensin II.

    Boutitie F, Oprisiu R, Achard JM, Mazouz H, Wang J, Messerli FH, Gueyffier F, Fournier A.

    J Hypertens. 2007 Aug;25(8):1543-53.PMID: 17620946 [PubMed - indexed for MEDLINE]Related articles

    16.

    Treatment of high blood pressure and gain in event-free life expectancy.

    Kassaï B, Boissel JP, Cucherat M, Boutitie F, Gueyffier F.

    Vasc Health Risk Manag. 2005;1(2):163-9.PMID: 17315403 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Safety of computerized drug management: a case report.

    Nguyen KA, Vial T, Gueyffier F, Marignier S, Cochat P, Kassai B; Paediatric Pharmacovigilance Working Group.

    Br J Clin Pharmacol. 2007 Feb;63(2):245-6. No abstract available. PMID: 17274791 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    [Smoking cessation counseling center in a French hospital: Effectiveness at one year and predictors of outcome]

    de la Blanchardière A, Depieds D, Gueyffier F.

    Presse Med. 2006 Oct;35(10 Pt 1):1447-52. French. PMID: 17028532 [PubMed - indexed for MEDLINE]Related articles

    19.

    [The difficulty of measurement of placebo effect]

    Boussageon R, Gueyffier F, Moreau A, Boussageon V.

    Therapie. 2006 May-Jun;61(3):185-90. Review. French. PMID: 16989117 [PubMed - indexed for MEDLINE]Related articles

    20.

    Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock.

    Monneret G, Lepape A, Voirin N, Bohé J, Venet F, Debard AL, Thizy H, Bienvenu J, Gueyffier F, Vanhems P.

    Intensive Care Med. 2006 Aug;32(8):1175-83. Epub 2006 Jun 2.PMID: 16741700 [PubMed - indexed for MEDLINE]Related articles

    21.

    Estimation of attributable burden of disease: authors' reply.

    Gueyffier F, Wright JM.

    J Hypertens. 2006 May;24(5):981-2. No abstract available. PMID: 16612262 [PubMed - indexed for MEDLINE]Related articles

    22.

    The lower the better: does simplicity lead to absurdity?

    Gueyffier F, Wright J.

    J Hypertens. 2006 Mar;24(3):431-3. No abstract available. PMID: 16467641 [PubMed - indexed for MEDLINE]Related articles

    23.

    [Cardiovascular prevention and large clinical trials]

    Gueyffier F.

    Rev Prat. 2005 Oct 31;55(16):1774-82. Review. French. PMID: 16363427 [PubMed - indexed for MEDLINE]Related articles

    24.

    Modelling and clinical trials in paediatrics.

    Jacqmin P, Labouret N, Gueyffier F; Round Table No. 6, Giens XX.

    Therapie. 2005 Jul-Aug;60(4):379-84, 385-90. English, French. PMID: 16268438 [PubMed - indexed for MEDLINE]Related articles

    25.

    Apparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments.

    Boissel JP, Gueyffier F, Boutitie F, Pocock S, Fagard R.

    Fundam Clin Pharmacol. 2005 Oct;19(5):579-84.PMID: 16176337 [PubMed - indexed for MEDLINE]Related articles

    26.

    The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests.

    Kassaï B, Shah NR, Leizorovicza A, Cucherat M, Gueyffier F, Boissel JP.

    J Clin Epidemiol. 2005 Oct;58(10):1042-51. Review.PMID: 16168350 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome.

    Wang JG, Staessen JA, Franklin SS, Fagard R, Gueyffier F.

    Hypertension. 2005 May;45(5):907-13. Epub 2005 Apr 18. Review.PMID: 15837826 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    [Hormonal treatment for menopause and arterial risk]

    Gueyffier F, Cornu C.

    Rev Prat. 2005 Feb 28;55(4):383-8. Review. French. PMID: 15828616 [PubMed - indexed for MEDLINE]Related articles

    29.

    [Readability of informed consent forms for subjects participating in biomedical research: updating is required]

    Paris A, Cracowski JL, Ravanel N, Cornu C, Gueyffier F, Deygas B, Guillot K, Bosson JL, Hommel M.

    Presse Med. 2005 Jan 15;34(1):13-8. French. PMID: 15685092 [PubMed - indexed for MEDLINE]Related articles

    30.

    Are guidelines right to promote lifestyle interventions against hypertension?

    Gueyffier F.

    J Hypertens. 2004 Nov;22(11):2055-6. Review. No abstract available. PMID: 15480085 [PubMed - indexed for MEDLINE]Related articles

    31.

    Another benefit from salt intake reduction?

    Gueyffier F.

    J Hypertens. 2004 Aug;22(8):1459-60. Review. No abstract available. PMID: 15257163 [PubMed - indexed for MEDLINE]Related articles

    32.

    Sub-group analyses: to do or not to do?

    Gueyffier F.

    J Hypertens. 2004 Mar;22(3):467-9. Review. No abstract available. PMID: 15076150 [PubMed - indexed for MEDLINE]Related articles

    33.

    [Preventing dependency in elderly persons: randomized study in the community]

    Cornu C, Carré C, Guetemme G, Ravis B, Thérond S, Gueyffier F, Bonnefoy M.

    Therapie. 2003 Sep-Oct;58(5):451-6. French. PMID: 14682195 [PubMed - indexed for MEDLINE]Related articles

    34.

    Editorial comment--Secondary prevention of stroke: beyond meta-analyses.

    Gueyffier F.

    Stroke. 2003 Nov;34(11):2748-9. Epub 2003 Oct 23. No abstract available. PMID: 14576371 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Absolute benefit, number needed to treat and gain in life expectancy: which efficacy indices for measuring the treatment benefit?

    Kassai B, Gueyffier F, Boissel JP, Boutitie F, Cucherat M.

    J Clin Epidemiol. 2003 Oct;56(10):977-82.PMID: 14568629 [PubMed - indexed for MEDLINE]Related articles

    36.

    How should therapeutic information be transferred to users?

    Boissel JP, Haugh M, Fardeheb M, Nony P, Gueyffier F, Strang N.

    Fundam Clin Pharmacol. 2003 Aug;17(4):495-503.PMID: 12914554 [PubMed - indexed for MEDLINE]Related articles

    37.

    [What is the place for intermediate outcomes one cardiovascular prevention is achieved?]

    Gueyffier F.

    Therapie. 2003 Jan-Feb;58(1):31-6. Review. French. PMID: 12822198 [PubMed - indexed for MEDLINE]Related articles

    38.

    [Causality and statistical association (2) Mechanical determinism and stochastic model]

    Gueyffier F, Cucherat M.

    Rev Prat. 2003 May 1;53(9):933-6. French. No abstract available. PMID: 12816029 [PubMed - indexed for MEDLINE]Related articles

    39.

    [Statistical cause and association (I). Critique of the cause]

    Gueyffier F.

    Rev Prat. 2003 Apr 15;53(8):817-9. French. No abstract available. PMID: 12793161 [PubMed - indexed for MEDLINE]Related articles

    40.

    Pharmacogenetics and responders to a therapy: theoretical background and practical problems.

    Boissel JP, Gueyffier F, Cucherat M, Bricca G.

    Clin Chem Lab Med. 2003 Apr;41(4):564-72. Review.PMID: 12747604 [PubMed - indexed for MEDLINE]Related articles

    41.

    Which, and how limited number of polymorphisms should be selected per disease, risk assessment, health profile or biological system?

    Masana L, Madan T, Visvikis S, Sass C, Baranova H, Bonnet J, Dembinska A, Ehrlich H, Gueyffier F, Schmitz G, Siest G, Zannis V.

    Clin Chem Lab Med. 2003 Apr;41(4):554-8. No abstract available. PMID: 12747602 [PubMed - indexed for MEDLINE]Related articles

    42.

    Observational epidemiological studies: values and limitations.

    Gueyffier F.

    J Hypertens. 2003 Apr;21(4):673-5. Review. No abstract available. PMID: 12658007 [PubMed - indexed for MEDLINE]Related articles

    43.

    Risk reduction for stroke and coronary events.

    Boissel JP, Gueyffier F, Boutitie F.

    Lancet. 2002 Apr 6;359(9313):1249; author reply 1250-1. No abstract available. PMID: 11955569 [PubMed - indexed for MEDLINE]Related articles

    44.

    J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data.

    Boutitie F, Gueyffier F, Pocock S, Fagard R, Boissel JP; INDANA Project Steering Committee. INdividual Data ANalysis of Antihypertensive intervention.

    Ann Intern Med. 2002 Mar 19;136(6):438-48.PMID: 11900496 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups.

    Gasowski J, Fagard RH, Staessen JA, Grodzicki T, Pocock S, Boutitie F, Gueyffier F, Boissel JP; INDANA Project Collaborators.

    J Hypertens. 2002 Jan;20(1):145-51.PMID: 11791038 [PubMed - indexed for MEDLINE]Related articles

    46.

    [Biological markers: utilization in drug development and approval]

    Gueyffier F, Dib M, Boissel JP.

    Therapie. 2001 Jul-Aug;56(4):355-61. French. PMID: 11677852 [PubMed - indexed for MEDLINE]Related articles

    47.

    A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials.

    Pocock SJ, McCormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel JP.

    BMJ. 2001 Jul 14;323(7304):75-81.PMID: 11451781 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    [Antihypertensive therapy and improved life expectancy without cerebrovascular accident or coronary artery disease]

    Kassaï B, Gueyffier F, Cucherat M, Boissel JP.

    Arch Mal Coeur Vaiss. 2001 Mar;94(3):211-7. French. PMID: 11338256 [PubMed - indexed for MEDLINE]Related articles

    49.

    Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials.

    Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, Coope J, Ekbom T, Gueyffier F, Liu L, Kerlikowske K, Pocock S, Fagard RH.

    Lancet. 2000 Mar 11;355(9207):865-72. Erratum in: Lancet 2001 Mar 3;357(9257):724. PMID: 10752701 [PubMed - indexed for MEDLINE]Related articles

    50.

    Models to predict cardiovascular risk: comparison of CART, multilayer perceptron and logistic regression.

    Colombet I, Ruelland A, Chatellier G, Gueyffier F, Degoulet P, Jaulent MC.

    Proc AMIA Symp. 2000:156-60.PMID: 11079864 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...